Field trials with a vaccine against porcine enzootic pneumonia (EP);Feldversuche mit einer Vakzine gegen die Enzootische Pneumonie (EP) der Schweine

Schweizer Archiv fur Tierheilkunde

Volumn 138, Issue 10, 1996, Pages 483-489

  Schatzmann, E ^a   Keller, H ^b   Grest, P ^c   Lorenz, D ^a   Burri, W ^d  

^a Schweinegesundheitsdienst GZ ^*

^b Veterinärmedizinische Klinik

^c UNIVERSITY OF ZURICH   (Switzerland)

^d Fritz Marti AG/Zanovit AG

Author keywords

Enzootic pneumonia; M. hyopneumoniae; Pig; Vaccination

Indexed keywords

BACTERIAL VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CONTAGIOUS PLEUROPNEUMONIA; FEMALE; GERMFREE ANIMAL; IMMUNOLOGY; LUNG; MALE; MYCOPLASMA; PATHOLOGY; SWINE; SWINE DISEASE; VACCINATION; WEIGHT GAIN;

ANIMALS; BACTERIAL VACCINES; FEMALE; LUNG; MALE; MYCOPLASMA; PLEUROPNEUMONIA, CONTAGIOUS; SPECIFIC PATHOGEN-FREE ORGANISMS; SWINE; SWINE DISEASES; VACCINATION; WEIGHT GAIN;

EID: 0030333667     PISSN: 00367281     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Charlier P, Jambers B., Martinod S., Legrand A. (1994): Efficacy of Stellamune Mycoplasma™ in European field trials. Proc. 13th IPVS Congr., Bangkok, p. 136.
2. Dayal K. I. (1994): Beneficial effects of a Mycoplasma hyopneumoniae Vaccine (Respisure™, Stellamune Mycoplasma™), as evaluated under both experimental and field conditions. Proc. 13th IPVS Congr., Bangkok, p. 137.
3. Goodwin R.F.W. (1985) Apparent re-infection of enzootic-pneumonia-free pig herds: search for possible causes. Vet. Rec 166, 690-694.
4. Jorsa S. E., Thomsen B. L. (1988): A cox regression analysis of risk factors related to Mycoplasma suipneumoniae reinfection in Danish SPF-herds. Acta Vet. Scand. Supp. 84, 436-438.
5. Keller H., Bertschinger H. U. (1968): Der Nachweis pleomorpher Organismen (PO) in der Diagnostik der Enzootischen Pneumonie der Schweine. Berl. Münch tierärztl. Wschr, 81, 101-107.
6. Le Foll P., Darre R. Sansot J. (1985): Pathologie respiratoire des porcs charcutiers: Bilan lésionel en Aquitaine. Revue Méd. vét. 136, 451-456.
7. Madsen P. (1988): 20 years with the Danish SPF-programme. Proc. 10th IPVS Congr., Rio de Janeiro, p 333.
8. Scheidt A. B., Mayrose V.B., Van Alstine W.G., Clark L. K., Cline T.R., Einstein M. E. (1994): The effects of vaccinating pigs for mycoplasmal pneumonia in a swine herd affected by enzootic pneumonia. Swine health and production Vol 2, 7-11.
9. Simon X., Sitjar M., Noyes E., Alcaide M. C., Fernandez de Aragon J., Pijoan C (1995): Relationship between lifetime pneumonia lesions, slaugter volumetric and superficial lung lesions and productive parameters in pigs Proc. 13th IPVS Congr., Bangkok, p. 132.
10. Stärk K., Keller H., Eggenberger E. (1992). Risk factors for the reinfection of specific pathogen-free breeding herds with enzootic pneumonia Vet. Rec 131, 532-535.
11. Waldmann O., Radtke G. (1937): Erster Bericht über Erfolge der Bekämpfung der Ferkelgrippe durch die Riemser Einzelhuttenanlage Berl tierärztl Wschr. 53, 241-246.
12. Whittlestone P (1967): Mycoplasma in enzootic pneumonia of pigs. Annales of the New York Academy of Sciences 143, Art. 1, 271.
13. Young G.A., Underdahl N. R. (1953): Isolation units for growing baby pigs without colostrum. J. Vet. Res 14, 571-574.
14. Zimmermann W., Odermatt W., Tschudi P. (1989) Enzootische Pneumonie (EP): Teilsanierung EP-reinfizierter Schweinezuchtbetriebe als Alternative zur Totalsanierung. Schweiz. Arch. Tierheilk. 131, 179-191.